Fontan-Associated Liver Disease: Monitoring Progression of Liver Fibrosis

Clinical Liver Disease - United Kingdom
doi 10.1002/cld.681
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Wiley

Related search

Fontan Associated Liver Disease and “Shock Liver”

Pediatric Cardiology and Cardiac Surgery
2017English

Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis

Liver Transplantation
HepatologyTransplantationSurgery
2019English

Steatohepatitis Is Not Associated With an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease

Gastroenterology Research and Practice
HepatologyGastroenterology
2018English

Sarcopenia Is Associated With Severe Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Liver Impairment Associated With Disease Progression in COVID-19 Patients

Liver International
Hepatology
2020English

The Enhanced Liver Fibrosis Test Is Associated With Liver-Related Outcomes in Postmenopausal Women With Risk Factors for Liver Disease

BMC Gastroenterology
MedicineGastroenterology
2020English

Liver Fibrosis Scores Predict Liver Disease Mortality in the United States Population

Hepatology
MedicineHepatology
2017English

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Accumulation of Duct Cells With Activated YAP Parallels Fibrosis Progression in Non-Alcoholic Fatty Liver Disease

Journal of Hepatology
Hepatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy